Fondaparinux Market | Industry Size, Share, Trends & Growth (2022-27)

 

Market Overview:

The fondaparinux market was worth approximately USD 505 million in 2020 and is expected to generate USD 725 million by 2027, at a CAGR of 6.20% over the forecast period.

COVID-19 has had a significant impact on the pharmaceutical supply chain, including the fondaparinux market. However, the use of heparin is associated with a lower mortality rate in COVID-19 patients. The study’s preliminary findings, published in the Journal of Cardiovascular Pharmacology in 2020, emphasized the safe and effective use of fondaparinux to reduce the rate of mortality among patients hospitalized with COVID-19 infection.

However, according to a study published in TH Open in 2020, the International Society on Thrombosis and Haemostasis Subcommittee recommended that only Low Molecular Weight Heparin be used for prophylaxis and treatment of venous thromboembolism in patients with mild or moderate COVID-19 infection. It did, however, recommend that fondaparinux be used to some extent due to its long half-life and lack of an antidote. As a result of the disparities in opinions regarding the use of fondaparinux in COVID-19 patients, the market under consideration is expected to be impacted during the COVID-19 pandemic.

Scope of the Report:

Fondaparinux is an anticoagulant that comes under the class of factor XA inhibitor that prevents the forming of clots in the blood.

Read Full Report

Comments

Popular Posts

Aviation Industry Set to Soar: Market to Hit USD 395.76 Billion by 2030 Amid Stable Growth

Recreational Boating Market Set to Reach USD 36.82 Billion by 2030: Key Growth Drivers and Trends

Kuwait Dairy Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Coffee Machine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)